$140 Million is the total value of DAFNA Capital Management LLC's 75 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 26.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LOXO | Buy | LOXO ONCOLOGY INC | $24,347,000 | +92.4% | 303,621 | +1.0% | 17.37% | +62.3% |
| ATRC | Sell | ATRICURE INC | $9,316,000 | -4.0% | 384,145 | -24.2% | 6.65% | -19.0% |
| IMMU | Buy | IMMUNOMEDICS INC | $5,631,000 | +244.6% | 637,700 | +152.5% | 4.02% | +190.7% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $5,611,000 | +164.5% | 106,770 | +128.3% | 4.00% | +123.2% |
| NXTM | NXSTAGE MEDICAL INC | $5,418,000 | -6.6% | 216,119 | 0.0% | 3.87% | -21.2% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $4,155,000 | +25.9% | 82,000 | -0.6% | 2.96% | +6.3% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $3,287,000 | -27.7% | 591,128 | +9.2% | 2.35% | -39.0% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $3,287,000 | +10.5% | 73,036 | -10.1% | 2.35% | -6.7% |
| PODD | INSULET CORP | $3,257,000 | +19.0% | 63,484 | 0.0% | 2.32% | +0.4% | |
| GLPG | Buy | GALAPAGOS NVspon adr | $2,954,000 | -3.1% | 38,609 | +9.2% | 2.11% | -18.2% |
| INSULET CORPnote 2.000% 6/1 | $2,746,000 | +8.2% | 2,250,000 | 0.0% | 1.96% | -8.7% | ||
| IBB | ISHARES TR NASDQ BIOTECetf | $2,698,000 | +5.8% | 8,700 | 0.0% | 1.92% | -10.8% | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $2,531,000 | -44.9% | 221,013 | 0.0% | 1.81% | -53.5% | |
| BEAT | BIOTELEMETRY INC | $2,509,000 | +15.6% | 75,000 | 0.0% | 1.79% | -2.5% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,507,000 | -1.0% | 54,508 | -6.8% | 1.79% | -16.5% |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $2,445,000 | +197.8% | 276,317 | +172.7% | 1.74% | +151.4% |
| RDUS | Buy | RADIUS HEALTH INC | $2,411,000 | +27.8% | 53,309 | +9.2% | 1.72% | +7.8% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $2,296,000 | -35.5% | 850,328 | -2.0% | 1.64% | -45.6% |
| DERM | Buy | DERMIRA INC | $2,200,000 | +130.4% | 75,500 | +169.6% | 1.57% | +94.3% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $2,147,000 | -24.3% | 421,000 | +2.4% | 1.53% | -36.1% |
| SPNC | Sell | SPECTRANETICS CORP | $2,146,000 | +12.5% | 55,896 | -14.7% | 1.53% | -5.1% |
| MGNX | MACROGENICS INC | $2,087,000 | -5.9% | 119,200 | 0.0% | 1.49% | -20.6% | |
| SGMO | New | SANGAMO THERAPEUTICS INC | $1,980,000 | – | 225,000 | +100.0% | 1.41% | – |
| CLLS | CELLECTIS S Asponsored adr | $1,973,000 | +7.6% | 76,404 | 0.0% | 1.41% | -9.2% | |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $1,951,000 | +201.1% | 135,738 | +92.7% | 1.39% | +154.0% |
| PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $1,936,000 | -1.4% | 2,500,000 | 0.0% | 1.38% | -16.8% | ||
| ARDX | Buy | ARDELYX INC | $1,904,000 | -32.1% | 373,409 | +68.4% | 1.36% | -42.7% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $1,835,000 | +94.4% | 204,808 | +187.2% | 1.31% | +64.0% |
| New | DERMIRA INCnote 3.000% 5/1 | $1,665,000 | – | 1,500,000 | +100.0% | 1.19% | – | |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $1,650,000 | +2.4% | 355,667 | +9.2% | 1.18% | -13.6% |
| ADXS | Buy | ADVAXIS INC | $1,603,000 | +14.1% | 247,000 | +43.6% | 1.14% | -3.7% |
| CDTX | CIDARA THERAPEUTICS INC | $1,563,000 | -3.9% | 208,458 | 0.0% | 1.12% | -18.9% | |
| NEOS | Buy | NEOS THERAPEUTICS INC | $1,532,000 | +123.3% | 209,873 | +120.3% | 1.09% | +88.4% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $1,346,000 | -48.4% | 349,592 | -0.2% | 0.96% | -56.5% |
| QURE | UNIQURE N V | $1,262,000 | +7.0% | 203,907 | 0.0% | 0.90% | -9.6% | |
| JNJ | JOHNSON AND JOHNSON | $1,244,000 | +6.2% | 9,400 | 0.0% | 0.89% | -10.3% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS | $1,223,000 | +47.9% | 266,500 | +35.6% | 0.87% | +24.9% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,211,000 | -22.7% | 443,478 | -6.3% | 0.86% | -34.8% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $1,190,000 | -12.4% | 377,695 | +11.2% | 0.85% | -26.1% |
| Buy | NEURODERM LTD | $1,134,000 | +14.1% | 37,938 | +1.3% | 0.81% | -3.8% | |
| ARQL | Sell | ARQULE INC | $973,000 | +13.8% | 784,508 | -2.8% | 0.69% | -4.0% |
| ELOS | SYNERON MEDICAL LTD | $941,000 | +3.7% | 85,947 | 0.0% | 0.67% | -12.5% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $922,000 | +80.8% | 33,214 | +82.4% | 0.66% | +52.7% |
| SCYX | Buy | SCYNEXIS INC | $907,000 | -13.9% | 506,900 | +32.7% | 0.65% | -27.4% |
| ARGX | New | ARGENX SEsponsored adr | $848,000 | – | 40,000 | +100.0% | 0.60% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $840,000 | +2.7% | 8,000 | -11.1% | 0.60% | -13.4% |
| BLRX | Sell | BIOLINERX LTDsponsored adr | $828,000 | -13.8% | 980,352 | -2.0% | 0.59% | -27.3% |
| ZGNX | Sell | ZOGENIX INC | $809,000 | +24.7% | 55,809 | -6.6% | 0.58% | +5.1% |
| STXS | STEREOTAXIS INC | $796,000 | +1.8% | 1,372,862 | 0.0% | 0.57% | -14.1% | |
| IRONWOOD PHARMACEUTICALS INCdbcv 2.250% 6/1 | $767,000 | +7.4% | 573,000 | 0.0% | 0.55% | -9.4% | ||
| EXAC | Sell | EXACTECH INC | $689,000 | -13.6% | 23,136 | -26.9% | 0.49% | -27.0% |
| CGNT | COGENTIX MEDICAL INC | $615,000 | -3.3% | 353,482 | 0.0% | 0.44% | -18.4% | |
| TNDM | TANDEM DIABETES CARE INC | $579,000 | -33.4% | 724,286 | 0.0% | 0.41% | -43.8% | |
| ITEK | INOTEK PHARMACEUTICALS CORP | $451,000 | -4.9% | 237,135 | 0.0% | 0.32% | -19.7% | |
| CASC | Sell | CASCADIAN THERAPEUTICS INC | $436,000 | -43.2% | 117,310 | -36.7% | 0.31% | -52.1% |
| GEMP | Sell | GEMPHIRE THERAPEUTICS INC | $394,000 | -28.9% | 30,797 | -41.7% | 0.28% | -40.1% |
| MASI | Buy | MASIMO CORPORATION | $388,000 | +19.0% | 4,250 | +21.4% | 0.28% | +0.4% |
| INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $369,000 | -0.8% | 600,000 | 0.0% | 0.26% | -16.5% | ||
| SRRA | SIERRA ONCOLOGY INC | $310,000 | -23.5% | 265,000 | 0.0% | 0.22% | -35.6% | |
| NTUS | New | NATUS MDICAL INC DEL | $295,000 | – | 7,900 | +100.0% | 0.21% | – |
| CNAT | New | CONATUS PHARMACEUTICALS INC | $288,000 | – | 50,000 | +100.0% | 0.21% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $284,000 | -31.1% | 35,977 | 0.0% | 0.20% | -41.7% | |
| ARNA | New | ARENA PHARMACEUTICALS INC | $262,000 | – | 15,550 | +100.0% | 0.19% | – |
| New | DEXCOM INCdbcv 0.750% 5/1 | $254,000 | – | 250,000 | +100.0% | 0.18% | – | |
| BLCM | BELLICUM PHARMACEUTICALS INC | $234,000 | -5.3% | 20,000 | 0.0% | 0.17% | -20.1% | |
| SBPH | New | SPRING BANK PHARMACEUTICALS | $217,000 | – | 1,600 | +100.0% | 0.16% | – |
| OBSV | OBSEVA SA | $214,000 | -17.7% | 25,000 | 0.0% | 0.15% | -30.5% | |
| EDGE | New | EDGE THERAPEUTICS INC | $199,000 | – | 19,400 | +100.0% | 0.14% | – |
| AFMD | AFFIMED N V | $190,000 | -10.8% | 92,500 | 0.0% | 0.14% | -24.4% | |
| ARRY | New | ARRAY BIOPHARMA INC | $167,000 | – | 20,000 | +100.0% | 0.12% | – |
| ANAB | Buy | ANAPTYSBIO INC | $132,000 | +5.6% | 5,500 | +22.2% | 0.09% | -11.3% |
| ADMP | Sell | ADAMIS PHARMACEUTICALS CORP | $127,000 | -0.8% | 24,401 | -18.7% | 0.09% | -15.7% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $110,000 | -71.0% | 19,067 | -78.3% | 0.08% | -75.7% |
| New | TRILLIUM THERAPEUTICS INC | $88,000 | – | 20,000 | +100.0% | 0.06% | – | |
| GALE | GALENA BIOPHARMA INC | $27,000 | -3.6% | 46,145 | 0.0% | 0.02% | -20.8% | |
| BPMX | Exit | BIOPHARMX CORP | $0 | – | -115,000 | -100.0% | -0.05% | – |
| TNXP | Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -20,000 | -100.0% | -0.08% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -53,525 | -100.0% | -0.12% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -55,700 | -100.0% | -0.18% | – |
| CYAD | Exit | CELYADadr | $0 | – | -12,528 | -100.0% | -0.28% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -67,537 | -100.0% | -0.29% | – |
| NVDQ | Exit | NOVADAQ TECHNOLOGIES INC | $0 | – | -95,841 | -100.0% | -0.63% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -95,322 | -100.0% | -1.48% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.